Pre-Market Technical Scan on Specialty Chemicals Equities — Venator Materials, W.R. Grace, Westlake Chemical, and Yield10 Bioscience

April 17, 2018 | By forimmediaterele | Filed in: Press Releases.

Travel & Tourism Industry release:

NEW YORK, April 17, 2018 /PRNewswire/ —

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on VNTR, GRA, WLK, and YTEN which can be accessed for free by signing up to www.wallstequities.com/registration. WallStEquities.com shifts focus on the Specialty Chemicals industry, which is engaged in the manufacturing, transporting, and selling of various chemical products including agricultural products, natural gas, and construction chemicals. In this morning’s lineup are the following stocks: Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), Westlake Chemical Corp. (NYSE: WLK), and Yield10 Bioscience Inc. (NASDAQ: YTEN). All you have to do is sign up today for this free limited time offer by clicking the link below. www.wallstequities.com/registration

Venator Materials

On Monday, shares in The Woodlands, Texas headquartered Venator Materials PLC recorded a trading volume of 436,266 shares. The stock ended the session 2.45% higher at $19.27. The Company’s shares have gained 1.80% in the last month. The stock is trading 1.35% below its 50-day moving average. Moreover, shares of Venator Materials, which manufactures and markets chemical products worldwide, have a Relative Strength Index (RSI) of 56.76.  

On April 09th, 2018, Venator Materials announced that its Q1 results will be released at approximately 6:00 a.m. ET on May 01st, 2018. The Company will hold a conference call at 9:00 a.m. ET that same day to discuss its results. The conference call will be available via live webcast and can be accessed on the Company’s investor relations website. Get the full research report on VNTR for free by clicking below at: www.wallstequities.com/registration/?symbol=VNTR

W.R. Grace

Columbia, Maryland headquartered W.R. Grace & Co.’s stock closed the day 1.07% higher at $66.80 with a total trading volume of 500,798 shares. The Company’s shares have advanced 1.58% in the past month. The stock is trading 1.90% above its 50-day moving average. Additionally, shares of W.R. Grace, which produces and sells specialty chemicals and materials worldwide, have an RSI of 62.48.  

On April 03rd, 2018, W.R. Grace completed the $416 million acquisition of the Polyolefin Catalysts business of Albemarle Corporation. The acquired business primarily develops and manufactures proprietary and custom-manufactured single-site catalysts as well as metallocenes and activators used in the production of plastic resins. The transaction also includes a comprehensive series of highly optimized Ziegler-Natta catalysts for polyethylene production. Free research on GRA can be accessed at: www.wallstequities.com/registration/?symbol=GRA

Westlake Chemical

Shares in Houston, Texas headquartered Westlake Chemical Corp. recorded a trading volume of 694,809 shares. The stock ended yesterday’s trading session 1.57% higher at $110.33. The Company’s shares have advanced 75.94% over the past year. The stock is trading above its 200-day moving average by 19.07%. Furthermore, shares of Westlake Chemical, which manufactures and markets basic chemicals, vinyls, polymers, and building products primarily in North America and Europe, have an RSI of 49.34.  

On March 19th, 2018, Westlake Chemical (WLK) announced that notices of redemption have been delivered for the optional redemption of all of the outstanding WLK 4.875% Senior Notes due 2023 ($433,793,000 aggregate principal amount) and all of the outstanding Axiall Corporation 4.875% Senior Notes due 2023 ($16,207,000 aggregate principal amount) (collectively, the “2023 Notes”). The 2023 Notes will be optionally redeemed on May 15th, 2018 at a redemption price equal to 102.438% of the principal amount of 2023 Notes, plus accrued and unpaid interest on the 2023 Notes to the redemption date.

On April 09th, 2018, research firm JP Morgan downgraded the Company’s stock rating from ‘Overweight’ to ‘Neutral’. Visit WallStEquities.com now and sign up for the free research on WLK at: www.wallstequities.com/registration/?symbol=WLK

Yield10 Bioscience

Woburn, Massachusetts headquartered Yield10 Bioscience Inc.’s stock finished Monday’s session 0.08% lower at $1.78 with a total trading volume of 159,493 shares. The Company’s shares have advanced 13.69% over the previous three months. The stock is trading above its 50-day moving average by 0.81%. Additionally, shares of Yield10 Bioscience, which engages in developing disruptive technologies for enhancing crop yield in the US, have an RSI of 48.23. The free technical report on YTEN is available at: www.wallstequities.com/registration/?symbol=YTEN

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Cision View original content:http://www.prnewswire.com/news-releases/pre-market-technical-scan-on-specialty-chemicals-equities—-venator-materials-wr-grace-westlake-chemical-and-yield10-bioscience-300631038.html

SOURCE Wall St. Equities

Click here to read the full release with contact information on PR Newswire. Some releases are not in English.

To post and circulate your own press release on FIR and the eTN Network  please click here 

 


Comments are closed here.